Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01987 |
| Species: | Homo sapiens |
| Position : | chr2:60722225-60722425 |
| Year: | 2020 |
| Title: | MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | non-small cell lung carcinoma |
| PMID: | 32170070 |
| MONDO: | MONDO:0005233 |
| Tissue: | Lung |
| Tissue Ontology ID: | UBERON:0002048 |
| Cell Source: | NSCLC cell lines |
| CVCL ID: | |
| Cell Type: | non-small cell lung carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | Amplicon deep sequencing, RNA-seq |
| Low Throughput Method: | CRISPR Base Editing, RT-RT-qPCR, HPLC, Flow Cytometry, Sickling Assay |
| Target gene : | BCL11A |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01591 | chr2:60722150-60722350 | Bone Marrow | hematopoietic stem cell | -- |